Edwards Lifesciences Corp (NYSE:EW)
$ 88.93 -1.18 (-1.31%) Market Cap: 53.59 Bil Enterprise Value: 53.27 Bil PE Ratio: 38.33 PB Ratio: 7.52 GF Score: 98/100

Edwards Lifesciences Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 05:00PM GMT
Release Date Price: $61.87 (+0.21%)
Veronika Dubajova
Goldman Sachs Group Inc., Research Division - Equity Analyst

Good morning, ladies and gentlemen, and thank you for joining us for another session here. My name is Veronika Dubajova, and I am a med tech analyst at Goldman Sachs. And it is with great pleasure this morning that I am joined by the management team from Edwards, Mike Mussallem, Chairman and CEO; and Scott Ullem, Chief Financial Officer. Gentlemen, thank you for being here. We really appreciate it.

This is meant to be an interactive session, so please raise your hands if you have a question. The session is webcast, so wait for mic before asking it. But I will kick us off and hopefully, we will have some questions from the audience as we go along.

Questions & Answers

Veronika Dubajova
Goldman Sachs Group Inc., Research Division - Equity Analyst

Mike, I want to start with a high-level question. You've obviously been at the helm of Edwards for a very long time. And I --if I look at -- yes, this is our 40th conference, and one of the things we looked at was which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot